Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 796, pseudogene (RN7SL796P)

Target
RN7SL796P
Molecular classification
Pseudogene, Non-coding RNA-derived element
01

Overview

RN7SL796P is a non-functional pseudogene derived from the RNA, 7SL gene, which encodes the 7SL RNA component of the signal recognition particle complex. The canonical 7SL RNA is essential for targeting nascent polypeptides to the membrane during protein synthesis, but RN7SL796P neither encodes for functional RNA nor is part of active SRP machinery. It represents a genomic remnant without coding potential or established biological/disease relevance[1][4][2]. Pseudogenes are typically classified as non-coding genetic elements that resemble known genes but have lost protein-coding ability due to mutations, deletions, or lack of regulatory sequences[2]. Some pseudogenes can act as competitive regulators of microRNAs or RNA-binding proteins in specific cases; however, there is no evidence that RN7SL796P exhibits such regulatory roles[2]. If structured information on a bona fide target is needed for drug development or signaling, the focus should shift to the functional RNA, 7SL (RN7SL1) gene[3][5][6], not to this pseudogene.

Other names
RNA, 7SL, cytoplasmic 796, pseudogeneRN7SL796P
02

Mechanism of action

None. No drugs act on this pseudogene.

03

Biological functions

None directly; as a pseudogene, RN7SL796P does not have a known biological function. Functional 7SL RNA participates in co-translational protein targeting, but pseudogenes generally do not contribute to this pathway
04

Disease associations

None established for RN7SL796P specifically.Some pseudogenes are implicated in disease processes, e.g., by competing for regulatory elements or acting as competing endogenous RNAs, but there is no documentation for a disease role for this specific pseudogene
05

Safety considerations

None relevant; as a pseudogene it is not therapeutically acted upon.
06

Interacting drugs

None. Therapeutics do not target RN7SL796P.
07

Biomarkers

None. It is not used as a biomarker in any established context.

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 796, pseudogene (RN7SL796P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 796, pseudogene (RN7SL796P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call